Author： Rancoule Chloéé Pradèère Jean-Philippe Gonzalez Julien Klein Julie Valet Philippe Bascands Jean-Loup Schanstra Joost P Saulnier-Blache Jean-Séébastien
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.5, 2011-05, pp. : 657-667
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Necessity of Lysophosphatidic Acid Receptor 1 for Development of Arthritis
Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. :
Access to resources
Recommend
Modulators of lysophosphatidic acid signalling
By Feng Li Mills Gordon B Prestwich Glenn D
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. :
Irritable Bowel Syndrome: New Agents Targeting Serotonin Receptor Subtypes
By De Ponti F.
Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. :